Yıl: 2020 Cilt: 23 Sayı: 2 Sayfa Aralığı: 169 - 179 Metin Dili: İngilizce DOI: 10.31086/tjgeri.2020.151 İndeks Tarihi: 22-10-2020

POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM

Öz:
Introduction: Polypharmacy has become a common health problem as populations age. We aimed to determine the prevalence of chronic and cumulative polypharmacy in the geriatric population using primary healthcare services in Turkey.Materials and Methods: The electronic prescriptions ordered by family physicians across Turkey for geriatric patients (≥65 years) in the Prescription Information System during 2018 were studied. Chronic polypharmacy criteria were proportion of patients who were given prescriptions containing ≥5 drugs four or more times during a year. Cumulative polypharmacy was defined as proportion of patients who were prescribed ≥5 drugs with different ATC4 codes in a month or in each quarter of the year.Results: Turkey’s total population is 82 million; 7,186,204 are aged 65 and over, constituting 8.8% of the total. Of this geriatric population, 6,104,798 (85.0%) had at least one prescription in 2018. Each geriatric patient had 6.4 prescriptions, with each prescription containing an average of 2.9 drugs with different fourth-level Anatomical Therapeutic Chemical codes. Each drug was prescribed in 2.7 boxes on average. Of these prescribed patients, 14.3% received prescriptions containing ≥5 drugs four or more times during 2018. The percentage of patients who received at least one prescription per month containing ≥5 drugs ranged between 16.4% and 20.7%. The most commonly prescribed drugs were acetylsalicylic acid, diclofenac, paracetamol, and pantoprazole.Conclusion: Polypharmacy is a critical health problem among geriatric population in Turkey as in other industrialized countries. Educating physicians as well as the public is essential to overcome polypharmacy.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Coskun Benlidayi I. Polypharmacy in geriatric rheumatology. Rheumatol Int 2019;39(6):1115-6. (PMID: 30810781).
  • 2. Bahat G, Tufan F, Akin S, Tufan A, Erten N, Karan MA: Rational drug use in the elderly. J Gerontol Geriat Res 2012;1:104. doi:10.4172/2167- 7182.1000104
  • 3. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr 2017;17(1):230. (PMID: 29017448).
  • 4. Pesante-Pinto JL. Clinical pharmacology and the risks of polypharmacy in the geriatric patient. Phys Med Rehabil Clin N Am 2017;28(4):739-46. (PMID: 29031340).
  • 5. Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of polypharmacy: methods. application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005;14(2):121-8. (PMID: 15386712).
  • 6. Carey IM, De Wilde S, Harris T, et al. What factors predict potentially inappropriate primary care prescribing in older people? Analysis of UK primary care patient record database. Drugs Aging 2008;25(8):693-706. (PMID: 18665661).
  • 7. Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K. Potentially inappropriate prescribing and cost outcomes for older people: a national population study. Br J Clin Pharmacol 2010;69(5):543-52. (PMID: 20573091).
  • 8. Grimmsmann T, Himmel W. Polypharmacy in primary care practices: an analysis using a large health insurance database. Pharmacoepidemiol Drug Saf 2009;18(12):1206-13. (PMID: 19795368).
  • 9. Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol 2018;10:289-98. (PMID: 29559811)
  • 10. Wastesson JW, Morin L, Laroche ML, Johnell K. How chronic is polypharmacy in old age? A longitudinal nationwide cohort study. J Am Geriatr Soc 2019;67(3):455-62. (PMID: 30575952).
  • 11. Turkish Statistical Institute. Population by Years. Age Group and Sex. Census of Population—ABPRS. 2018. [Internet] Available from: http://www.turkstat.gov.tr/ UstMenu.do?metod=temelist. Accessed: 1.12.2019.
  • 12. Aksoy M, Alkan A, İşli F. Rational drug use promotional activities of Ministry of Health. Turkiye Klinikleri J Pharmacol-Special Topics 2015;3(1):19-26.
  • 13. WHO Collaborating Centre for Drug Statistics Methodology. Anatomical Therapeutic Chemical (ATC) classification system. [Internet] Available from: https://www.who.int/classifications/atcddd/en/. Accessed: 1.12.2019.
  • 14. Qato DM, Wilder J, Schumm LP, Gillet V, Alexander GC. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med 2016;176(4):473-82. (PMID: 26998708).
  • 15. Glinz D, Leon Reyes S, Saccilotto R, et al. Quality of antibiotic prescribing of Swiss primary care physicians with high prescription rates: a nationwide survey. J Antimicrob Chemother 2017;72(11):3205-12. (PMID: 28961815).
  • 16. Pouwels KB, Hopkins S, Llewelyn MJ, Walker AS, McNulty CA, Robotham JV. Duration of antibiotic treatment for common infections in English primary care: cross sectional analysis and comparison with guidelines. BMJ 2019;364:l440. (PMID: 30814052).
  • 17. OECD Health Care Quality Framework. Health Care Quality Indicators, 2016. [Internet] Available from: https://stats.oecd.org/Index.aspx?QueryId=69051 Accessed: 1.2.2020
  • 18. Şayir ÇT , Karaoğlu SA, Toprak DE. Evaluation of polypharmacy and complementary therapy use in patients ≥65 years, attending to Family Medicine Outpatient Clinic of Şişli Etfal Training and Research Hospital. Türk Aile Hek Derg 2014;18:35-41. doi:10.2399/tahd.14.35220
  • 19. Gutiérrez-Valencia M, Aldaz Herce P, Lacalle-Fabo E, Contreras Escámez B, Cedeno-Veloz B, Martínez- Velilla N. Prevalence of polypharmacy and associated factors in older adults in Spain: Data from the National Health Survey 2017. Med Clin (Barc) 2019;153(4):141- 50. (PMID: 30803798).
  • 20. Ersoy S, Engin VS. Accessibility to healthcare and risk of polypharmacy on chronically ill patients. J Coll Physicians Surg Pak 2019;29(6):505-10. (PMID: 31133145).
  • 21. Kurt M, Akdeniz M, Kavukcu E. Assessment of Comorbidity and Use of Prescription and Nonprescription Drugs in Patients Above 65 Years Attending Family Medicine Outpatient Clinics. Gerontol Geriatr Med 2019 6;5:2333721419874274. (PMID: 31523700).
  • 22. Thorell K, Midlöv P, Fastbom J, Halling A. Use of potentially inappropriate medication and polypharmacy in older adults: a repeated crosssectional study. BMC Geriatr 2020;20(1):73. (PMID: 32075586).
  • 23. Mannucci PM, Nobili A, Pasina L; REPOSI Collaborators (REPOSI is the acronym of REgistro POliterapie SIMI, Società Italiana di Medicina Interna). Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register. Intern Emerg Med 2018;13(8):1191-200. (PMID: 30171585).
  • 24. Guisado-Clavero M, Violán C, López-Jimenez T, et al. Medication patterns in older adults with multimorbidity: a cluster analysis of primary care patients. BMC Fam Pract 2019;20(1):82. (PMID: 31195985).
  • 25. Gencer MZ, Arica S. Use of polypharmacy and herbal medication on quality of life in elderly patients at Okmeydani hospital’s polyclinics in Istanbul, Turkey. J Pak Med Assoc 2017 67(6):895-900. PubMed (PMID: 28585589).
APA AYDOS T, Emre Aydıngöz S, Lux K, EFE O, İŞLI F, Aksoy M, KADI E (2020). POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. , 169 - 179. 10.31086/tjgeri.2020.151
Chicago AYDOS Tolga Reşat,Emre Aydıngöz Selda,Lux Karl Michael,EFE Oğuzhan Ekin,İŞLI Fatma,Aksoy Mesil,KADI Esma POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. (2020): 169 - 179. 10.31086/tjgeri.2020.151
MLA AYDOS Tolga Reşat,Emre Aydıngöz Selda,Lux Karl Michael,EFE Oğuzhan Ekin,İŞLI Fatma,Aksoy Mesil,KADI Esma POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. , 2020, ss.169 - 179. 10.31086/tjgeri.2020.151
AMA AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. . 2020; 169 - 179. 10.31086/tjgeri.2020.151
Vancouver AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. . 2020; 169 - 179. 10.31086/tjgeri.2020.151
IEEE AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E "POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM." , ss.169 - 179, 2020. 10.31086/tjgeri.2020.151
ISNAD AYDOS, Tolga Reşat vd. "POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM". (2020), 169-179. https://doi.org/10.31086/tjgeri.2020.151
APA AYDOS T, Emre Aydıngöz S, Lux K, EFE O, İŞLI F, Aksoy M, KADI E (2020). POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi, 23(2), 169 - 179. 10.31086/tjgeri.2020.151
Chicago AYDOS Tolga Reşat,Emre Aydıngöz Selda,Lux Karl Michael,EFE Oğuzhan Ekin,İŞLI Fatma,Aksoy Mesil,KADI Esma POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi 23, no.2 (2020): 169 - 179. 10.31086/tjgeri.2020.151
MLA AYDOS Tolga Reşat,Emre Aydıngöz Selda,Lux Karl Michael,EFE Oğuzhan Ekin,İŞLI Fatma,Aksoy Mesil,KADI Esma POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi, vol.23, no.2, 2020, ss.169 - 179. 10.31086/tjgeri.2020.151
AMA AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi. 2020; 23(2): 169 - 179. 10.31086/tjgeri.2020.151
Vancouver AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM. Türk Geriatri Dergisi. 2020; 23(2): 169 - 179. 10.31086/tjgeri.2020.151
IEEE AYDOS T,Emre Aydıngöz S,Lux K,EFE O,İŞLI F,Aksoy M,KADI E "POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM." Türk Geriatri Dergisi, 23, ss.169 - 179, 2020. 10.31086/tjgeri.2020.151
ISNAD AYDOS, Tolga Reşat vd. "POLYPHARMACY PREVALENCE AMONG GERIATRIC PATIENTS IN PRIMARY HEALTHCARE SETTINGS ACROSS TURKEY: A CROSS-SECTIONAL ANALYSIS THROUGH THE NATIONWIDE PRESCRIPTION INFORMATION SYSTEM". Türk Geriatri Dergisi 23/2 (2020), 169-179. https://doi.org/10.31086/tjgeri.2020.151